bioRxiv · 10.1101/2024.02.03.578772
BayVarC: an ultra-sensitive ctDNA variant caller using Bayesian approach
Abstract
In liquid biopsy, it is critical to detect variants of allele frequencies as low as 0.1% or even lower, especially when used to monitor secondary resistant mutations and minimal residual disease. Despite the efforts on improving experimental design, it remains challenging to distinguish low-frequency variants from technical noises in the downstream bioinformatic analysis. Here, we introduce BayVarC, a novel variant caller specifically designed for variant calling in liquid biopsy. It applies Bayesian inference to accurately quantify noise level in a locus-specific manner, enabling the discrimination between technical noise and low-frequency cancer variants. Detailed in-silico simulation and in-vitro experiments demonstrated BayVarC superior performance over existing state-of-the-art tools. BayVarC can effectively detect low frequency variants while maintaining low false positive rate (0.05 FP/KB). Meanwhile, it achieves Limit of Detection (LoD) as low as 0.1%. Furthermore, empowered by its architecture, BayVarC shows promising applicability in Minimal Residual Disease (MRD) detection. BayVarC is freely available at https://github.com/GenetronBioinfomatics/BayVarC.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Che, D., Yan, C., Zha, J., Niu, Z., Yang, Q., Cheng, X., Han, M., Du, C., Zhang, K., Hu, Y., Yang, Y.-F.. 2024-02-07. BayVarC: an ultra-sensitive ctDNA variant caller using Bayesian approach. https://doi.org/10.1101/2024.02.03.578772
Cite the original work for its findings. Save a collection to share your selection of sources.